nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Parotitis—Etoposide—peripheral nervous system neoplasm	0.111	0.111	CcSEcCtD
Trihexyphenidyl—Forgetfulness—Tretinoin—peripheral nervous system neoplasm	0.0644	0.0644	CcSEcCtD
Trihexyphenidyl—Forgetfulness—Isotretinoin—peripheral nervous system neoplasm	0.0644	0.0644	CcSEcCtD
Trihexyphenidyl—Forgetfulness—Alitretinoin—peripheral nervous system neoplasm	0.0488	0.0488	CcSEcCtD
Trihexyphenidyl—Blindness—Tretinoin—peripheral nervous system neoplasm	0.0244	0.0244	CcSEcCtD
Trihexyphenidyl—Blindness—Isotretinoin—peripheral nervous system neoplasm	0.0244	0.0244	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Vincristine—peripheral nervous system neoplasm	0.0228	0.0228	CcSEcCtD
Trihexyphenidyl—Blindness—Alitretinoin—peripheral nervous system neoplasm	0.0185	0.0185	CcSEcCtD
Trihexyphenidyl—Blindness—Vincristine—peripheral nervous system neoplasm	0.0178	0.0178	CcSEcCtD
Trihexyphenidyl—Memory impairment—Tretinoin—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Trihexyphenidyl—Memory impairment—Isotretinoin—peripheral nervous system neoplasm	0.0172	0.0172	CcSEcCtD
Trihexyphenidyl—Blindness—Cisplatin—peripheral nervous system neoplasm	0.0157	0.0157	CcSEcCtD
Trihexyphenidyl—Memory impairment—Alitretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.00957	0.00957	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.00957	0.00957	CcSEcCtD
Trihexyphenidyl—Dry skin—Isotretinoin—peripheral nervous system neoplasm	0.00898	0.00898	CcSEcCtD
Trihexyphenidyl—Dry skin—Tretinoin—peripheral nervous system neoplasm	0.00898	0.00898	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Alitretinoin—peripheral nervous system neoplasm	0.00879	0.00879	CcSEcCtD
Trihexyphenidyl—Blindness—Epirubicin—peripheral nervous system neoplasm	0.00808	0.00808	CcSEcCtD
Trihexyphenidyl—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.00766	0.00766	CcSEcCtD
Trihexyphenidyl—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.00766	0.00766	CcSEcCtD
Trihexyphenidyl—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00755	0.00755	CcSEcCtD
Trihexyphenidyl—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00755	0.00755	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—peripheral nervous system neoplasm	0.00748	0.00748	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.00725	0.00725	CcSEcCtD
Trihexyphenidyl—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.0068	0.0068	CcSEcCtD
Trihexyphenidyl—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00674	0.00674	CcSEcCtD
Trihexyphenidyl—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00674	0.00674	CcSEcCtD
Trihexyphenidyl—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.0058	0.0058	CcSEcCtD
Trihexyphenidyl—Tension—Tretinoin—peripheral nervous system neoplasm	0.00579	0.00579	CcSEcCtD
Trihexyphenidyl—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00579	0.00579	CcSEcCtD
Trihexyphenidyl—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Trihexyphenidyl—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Trihexyphenidyl—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Trihexyphenidyl—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Trihexyphenidyl—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00556	0.00556	CcSEcCtD
Trihexyphenidyl—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00556	0.00556	CcSEcCtD
Trihexyphenidyl—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00542	0.00542	CcSEcCtD
Trihexyphenidyl—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00542	0.00542	CcSEcCtD
Trihexyphenidyl—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00511	0.00511	CcSEcCtD
Trihexyphenidyl—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00492	0.00492	CcSEcCtD
Trihexyphenidyl—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Trihexyphenidyl—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Trihexyphenidyl—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Trihexyphenidyl—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Trihexyphenidyl—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00464	0.00464	CcSEcCtD
Trihexyphenidyl—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Trihexyphenidyl—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Trihexyphenidyl—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Trihexyphenidyl—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Trihexyphenidyl—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Trihexyphenidyl—Constipation—Topotecan—peripheral nervous system neoplasm	0.00415	0.00415	CcSEcCtD
Trihexyphenidyl—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Trihexyphenidyl—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Trihexyphenidyl—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Trihexyphenidyl—Agitation—Vincristine—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Trihexyphenidyl—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Trihexyphenidyl—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Trihexyphenidyl—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Trihexyphenidyl—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Trihexyphenidyl—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Trihexyphenidyl—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Trihexyphenidyl—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Trihexyphenidyl—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Trihexyphenidyl—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Trihexyphenidyl—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Trihexyphenidyl—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Trihexyphenidyl—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Trihexyphenidyl—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Trihexyphenidyl—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Trihexyphenidyl—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Trihexyphenidyl—Rash—Topotecan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Trihexyphenidyl—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Trihexyphenidyl—Headache—Topotecan—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Trihexyphenidyl—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Trihexyphenidyl—Rash—Tretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Trihexyphenidyl—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Trihexyphenidyl—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Trihexyphenidyl—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Trihexyphenidyl—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Trihexyphenidyl—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Trihexyphenidyl—Headache—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Trihexyphenidyl—Constipation—Vincristine—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Trihexyphenidyl—Rash—Melphalan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Trihexyphenidyl—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Trihexyphenidyl—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Trihexyphenidyl—Nausea—Topotecan—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Trihexyphenidyl—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Trihexyphenidyl—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Trihexyphenidyl—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Trihexyphenidyl—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Trihexyphenidyl—Nausea—Melphalan—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Trihexyphenidyl—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Trihexyphenidyl—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Trihexyphenidyl—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Trihexyphenidyl—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Trihexyphenidyl—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Trihexyphenidyl—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Trihexyphenidyl—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Trihexyphenidyl—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Trihexyphenidyl—Constipation—Etoposide—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Trihexyphenidyl—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Trihexyphenidyl—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Trihexyphenidyl—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Trihexyphenidyl—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Trihexyphenidyl—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Trihexyphenidyl—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Trihexyphenidyl—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Trihexyphenidyl—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Trihexyphenidyl—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Trihexyphenidyl—Rash—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Trihexyphenidyl—Headache—Vincristine—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Trihexyphenidyl—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Trihexyphenidyl—Nausea—Vincristine—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Trihexyphenidyl—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Trihexyphenidyl—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Trihexyphenidyl—Rash—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Trihexyphenidyl—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Trihexyphenidyl—Tension—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Trihexyphenidyl—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Trihexyphenidyl—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Trihexyphenidyl—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Trihexyphenidyl—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Trihexyphenidyl—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Trihexyphenidyl—Agitation—Epirubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Trihexyphenidyl—Rash—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Trihexyphenidyl—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Trihexyphenidyl—Headache—Etoposide—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Trihexyphenidyl—Nausea—Etoposide—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Trihexyphenidyl—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Trihexyphenidyl—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Trihexyphenidyl—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Trihexyphenidyl—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Trihexyphenidyl—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Trihexyphenidyl—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Trihexyphenidyl—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Trihexyphenidyl—Rash—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Trihexyphenidyl—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Trihexyphenidyl—Headache—Epirubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Trihexyphenidyl—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000948	0.000948	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000939	0.000939	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.000925	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000877	0.000877	CcSEcCtD
